Status
Conditions
About
This investigation will be conducted to obtain the following information regarding the use of Humira 40 mg Syringe 0.8 mL for Subcutaneous Injection in patients with Ulcerative Colitis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Contraindications according to the Package Insert include patients who have any of the following:
1,621 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal